Lazard Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,336	Closed	-$233K	–	2530
2023 Q2	$233K	Sell	7,336 -744	-9%	-$23.6K	﹤0.01%	1305
2023 Q1	$197K	Sell	8,080 -2,078	-20%	-$50.7K	﹤0.01%	1316
2022 Q4	$320K	Buy	+10,158	New	+$320K	﹤0.01%	1199